SCHEMBL17131382

SCHEMBL17131382

CCCCOC[C@H]1O[C@@](O)(c2cnc3c(SC)ncnn23)[C@H](OCCCC)[C@@H]1OCCCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17130311 1.00 — —
SCHEMBL15605954 0.87 — —
SCHEMBL17130412 0.86 — —
SCHEMBL17131380 0.86 — —
SCHEMBL15259018 0.78 — —
SCHEMBL18359792 0.78 — —
SCHEMBL10142421 0.76 — —
SCHEMBL10143786 0.76 — —
SCHEMBL17130321 0.76 GJB2 (0.30) —
SCHEMBL15606972 0.74 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9777035-B2 4′-substituted nucleoside reverse transcriptase inhibitors MERCK SHARP & DOHME CORP. (US) 2017-10-03 — — US disclosed
US-20150274767-A1 4'-SUBSTITUTED NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS MERCK SHARP & DOHME CORP. (US) 2015-10-01 — — US disclosed
Send feedback